Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal... (tion withits lead product candidates bav...)

Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008

Date:3/11/2008

tion with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to the risk that the company may experience delays in clinical trial patient enrollment, the risk that future clinical trial results may not correlate with the results of prior clinical trials and preclinical studies, the risk that Avid's revenue growth may slow or decline, the risk that future protocol submissions may not be approved, the risk that the company may not be able to monetize any of its assets, the risk that the company will not regain compliance with the Nasdaq Stock Market minimum bid price requirement by July 21, 2008, and the risk that the company will not have additional high profile scientific publications and presentations. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related biology technology :

1. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
5. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
6. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
7. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference

Post Your Comments:

(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...

(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, The Future ... to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The ... Future of Orphan Diseases Therapeutics - Market ...

(Date:12/15/2009)... diameter NeedleProbes™ for Atomic Force Microscopy (AFM) have been ... for studies at the liquid/air interface. The NeedleProbes’ cylindrical ... height, evaporation rate and viscosity - all in a single ... ... December 15, 2009 -- New, constant diameter NeedleProbes ...

(Date:12/15/2009)... Center for Business Intelligence (CBI), a division ... the full agenda for the 6th ... The forum will take place at the ... Over 1,500 senior-level Finance, Accounting, Audit and ... since its inception, and this year,s meeting ...

[0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM [0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress

... SOMERSET, N.J., Dec. 1 The Tiger and Jacky ... , Terumo Interventional ... coronary diagnostic catheters, featuring the exclusive Tiger and,Jacky tip ... "The Optitorque catheters, ...

... the biofuel market is estimated at 33 billion with a double ... 15% biodiesel. Bioethanol is produced and consumed mainly in Brazil and ... in biodiesel production and this fuel represents about ¾ of the ... ...

... BMP Sunstone,Corporation (Nasdaq: BJGP ) ("BMP Sunstone" ... the 20th Annual Piper Jaffray Health Care,Conference. , ... Jaffray Health Care Conference is being held from,Tuesday, December ... New York,Palace Hotel in New York City. Management is ...

Other Biology Technology:Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters 2 Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters 3 CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market 2 CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market 3 CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market 4

Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference

(Date:12/15/2009)... Va., Dec. 15 The PTR Group, a ... announced that it has agreed to sponsor three high ... FIRST Robotics Competition ( http://usfirst.org ). ,, ... school teams in three different states. The teams ... Rockwall, TX, and James Madison HS in Vienna, VA ...

(Date:12/14/2009)... fuel that could help wean the nation from oil, ... with gasoline, especially in winter, according to a new ... from both gasoline and E85, a blend of gasoline ... in warm sunny weather than during the cold weather ... contribute to ozone formation. But E85 produces different byproducts ...

(Date:12/14/2009)... the holidays with big Uncle Frank or bossy Aunt ... with another family, spare a thought for the humble ... University and the University of New South Wales has ... groups, members make strategic decisions about their living situation. ... of Biology Letters . , The helper class ...

Breaking Biology News(10 mins):The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2 Ethanol-powered vehicles generate more ozone than gas-powered ones 2 Ethanol-powered vehicles generate more ozone than gas-powered ones 3 Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 1 Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 2 The Mills Group LLC Announces ElderCare PrimePlus Service 53178 1 The Mills Group LLC Announces ElderCare PrimePlus Service 53178 2 All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 1 All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 2

[0] The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams [0] Ethanol-powered vehicles generate more ozone than gas-powered ones [0] When it comes to fish families, the bigger and bossier the better

... A team of researchers led by scientists at Memorial Sloan-Kettering ... -- now in early stage clinical trials -- work best ... a protein that plays a central role in the growth ... majority of patients with melanoma and in a minority of ...

... being used in animal models ?to treat cancer by disrupting ... of Medicine completed a study in mice in which they ... then to treat it with a continuous wave of low-level ... to what is used in physiotherapy ultrasound (about 2.5 watts), ...

... According to research reported this week in Current Biology, ... of the 2004 Sumatra-Andaman earthquake was occasionally spectacular, but ... human misuse in the region. , Less than ... a team of ecologists from James Cook University, the ...

Other Biology News:Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs 2 Penn researchers study the use of ultrasound for treatment of cancer 2

Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs Penn researchers study the use of ultrasound for treatment of cancer Health of Acehnese reefs in the wake of the tsunami shows human impacts more harmful

... Alsevers solution is an isotonic, balanced salt ... preservative, which permits the storage of whole blood ... usage, an equal volume of blood is collected ... but thoroughly, mixed. The solution is placed in ...

... for routine procedures. Hollandes contains formaldehyde for ... decalcify small bone specimens. Tissue that is ... with most stains, and the cupric acetate ... membranes and cosinophil and endocrine cell granules ...

Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...

... GCMS-QP2010s Gas Chromatograph/Mass Spectrometer, utilizing many ... GCMS-QP2010 Plus, offers high throughput and ... excellent performance-to-cost ratio. Like the GCMS-QP2010 ... linear velocity for optimum separation, 20 ...

Biology Products:

Alsever's Solution from Sigma-Aldrich Hollande's Fixative from ScyTek Laboratories Rabbit Anti-GST Polyclonal Antibody, Unconjugated from Novus Biologicals QP-2010s Gas Chromatograph/Mass Spectrometer from Shimadzu

Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal...(tion withits lead product candidates bav...)